Koselugo
Brand Name: Koselugo
Generic Name: Selumetinib sulfate
Active
Registration Number
DR-XY49395
Dosage Form
Capsule
Issuance Date
May 14, 2025
Expiry Date
May 14, 2030
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength10 mg
Packaging75 mL HDPE Plastic Bottle with Blue Child-Resistant
e with PP Closure (Box of 60's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic Agent (Protein Kinase Inhibitor)
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Selumetinib sulfateActive
Monograph: Selumetinib